Clinical features | | | | | |
Age at onset (years) | 40 | 50 | 44 | 37 | 63 |
Sex | F | M | F | F | M |
Prominent ptosis | – | – | + | – | – |
Muscle fatiguability (at disease onset) | – | – | – | – | – |
Subacute disease manifestation | + | + | + | + | + |
Number of episodes | 7 | 5 | 2 | 4 | 4 |
Mean duration of episodes (weeks)* | 3 | 12 | 2 | 9 | 6 |
Generalisation | – | – | – | – | + |
Concomitant diseases | – | – | Hypothyreosis | – | – |
Diagnostic findings at disease onset | – | – | – | – | – |
MRI lesions in orbita/cerebrum | – | – | – | – | – |
Tensilon test | – | – | – | – | – |
Decrement in repetitive nerve stimulation (5 Hz) | – | – | – | – | – |
Anti-AChR antibodies | – | – | – | – | – |
Diagnosis initially proposed | Midbrain lesion | Incomplete external oculomotor nerve paresis | Bilateral external oculomotor nerve paresis | Abducens nerve paresis | Tolosa-Hunt syndrome |